10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 314 filers reported holding 10X GENOMICS INC in Q1 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $328,131 | -97.4% | 6,585 | -97.0% | 0.00% | -100.0% |
| Q2 2023 | $12,865,746 | +1503.9% | 221,251 | +909.2% | 0.00% | – |
| Q4 2022 | $802,163 | -0.2% | 21,923 | -2.1% | 0.00% | – |
| Q3 2022 | $804,000 | +232.2% | 22,393 | +354.9% | 0.00% | – |
| Q2 2022 | $242,000 | -17.4% | 4,923 | +26.6% | 0.00% | – |
| Q1 2022 | $293,000 | -94.2% | 3,890 | -88.4% | 0.00% | -100.0% |
| Q4 2021 | $5,080,000 | -12.1% | 33,637 | -14.7% | 0.00% | 0.0% |
| Q3 2021 | $5,782,000 | -24.2% | 39,433 | +4.2% | 0.00% | -25.0% |
| Q2 2021 | $7,628,000 | +8.5% | 37,839 | +2.4% | 0.00% | -20.0% |
| Q1 2021 | $7,030,000 | +4134.9% | 36,950 | +3632.3% | 0.01% | – |
| Q4 2020 | $166,000 | -88.1% | 990 | -90.3% | 0.00% | -100.0% |
| Q3 2020 | $1,393,000 | +23116.7% | 10,185 | +16327.4% | 0.00% | – |
| Q2 2020 | $6,000 | +200.0% | 62 | +55.0% | 0.00% | – |
| Q1 2020 | $2,000 | -33.3% | 40 | 0.0% | 0.00% | – |
| Q4 2019 | $3,000 | – | 40 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 8,185,565 | $952,538,000 | 99.56% |
| Foresite Capital Management I, LLC | 2,750,000 | $342,870,000 | 96.54% |
| Foresite Capital Management II, LLC | 3,503,528 | $436,820,000 | 95.05% |
| 12 West Capital Management LP | 1,922,000 | $239,635,000 | 11.66% |
| FINANCIAL CONSULATE, INC | 163,366 | $20,368,000 | 9.67% |
| JS Capital Management LLC | 606,400 | $75,606,000 | 3.91% |
| Asymmetry Capital Management, L.P. | 43,512 | $5,425,000 | 3.49% |
| Pinz Capital Management, LP | 55,400 | $6,907,000 | 2.52% |
| HAMILTON LANE ADVISORS LLC | 37,087 | $4,624,000 | 2.24% |
| RTW INVESTMENTS, LP | 660,933 | $82,405,000 | 1.98% |